Inaktiver Wert

ZS Pharma Inc Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

AstraZeneca : potassium drug delayed by manufacturing snag	27.05.16
ZS Pharma : AstraZeneca completes acquisition of ZS Pharma	22.12.15
AbbVie : AstraZeneca buys most of Acerta for $4 billion to add cancer drug	17.12.15
AbbVie : AstraZeneca buys most of Acerta for $4 billion to add cancer drug	17.12.15
AbbVie : AstraZeneca chases Acerta to secure next cancer drug winner	14.12.15

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	+3,91 %	109 Mrd.
REGENERON PHARMACEUTICALS, INC.	+10,87 %	105 Mrd.
ARGENX SE	+1,28 %	22,25 Mrd.
BIONTECH SE	-13,14 %	22,09 Mrd.
GENMAB A/S	-7,05 %	18,68 Mrd.
WUXI APPTEC CO., LTD.	-38,36 %	17,58 Mrd.
BEIGENE, LTD.	-10,66 %	16,85 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+3,75 %	13,76 Mrd.
SAREPTA THERAPEUTICS, INC.	+36,70 %	12,46 Mrd.